{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:56:52Z","timestamp":1781758612384,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T00:00:00Z","timestamp":1311033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/nrneph.2011.91","type":"journal-article","created":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T09:47:33Z","timestamp":1311068853000},"page":"509-516","source":"Crossref","is-referenced-by-count":61,"title":["Mechanisms and treatment of extraosseous calcification in chronic kidney disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Markus","family":"Ketteler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Biggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schlieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,19]]},"reference":[{"key":"BFnrneph201191_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","volume":"43","author":"WG Goodman","year":"2004","unstructured":"Goodman, W. G. et al. for the Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am. J. Kidney Dis. 43, 572\u2013579 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201191_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/01.HYP.0000219635.51844.da","volume":"47","author":"M Ketteler","year":"2006","unstructured":"Ketteler, M., Schlieper, G. & Floege, J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 47, 1027\u20131034 (2006).","journal-title":"Hypertension"},{"key":"BFnrneph201191_CR3","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. 113, S1\u2013S130 (2009)."},{"key":"BFnrneph201191_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MNH.0b013e32830dcd5c","volume":"17","author":"AP Gu\u00e9rin","year":"2008","unstructured":"Gu\u00e9rin, A. P., Pannier, B., M\u00e9tivier, F., Marchais, S. J. & London, G. M. Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 17, 635\u2013641 (2008).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph201191_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1253\/circj.69.1535","volume":"69","author":"T Ohara","year":"2005","unstructured":"Ohara, T., Hashimoto, Y., Matsumura, A., Suzuki, M. & Isobe, M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ. J. 69, 1535\u20131539 (2005).","journal-title":"Circ. J."},{"key":"BFnrneph201191_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1681\/ASN.2009080829","volume":"21","author":"G Schlieper","year":"2010","unstructured":"Schlieper, G. et al. Ultrastructural analysis of vascular calcifications in uremia. J. Am. Soc. Nephrol. 21, 689\u2013696 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR7","doi-asserted-by":"publisher","first-page":"22144","DOI":"10.1074\/jbc.M300744200","volume":"278","author":"PA Price","year":"2003","unstructured":"Price, P. A. & Lim, J. E. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J. Biol. Chem. 278, 22144\u201322152 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201191_CR8","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1074\/jbc.M305199200","volume":"279","author":"PA Price","year":"2004","unstructured":"Price, P. A., Williamson, M. K., Nguyen, T. M. & Than, T. N. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J. Biol. Chem. 279, 1594\u20131600 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201191_CR9","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1074\/jbc.M709938200","volume":"283","author":"A Heiss","year":"2008","unstructured":"Heiss, A. et al. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J. Biol. Chem. 283, 14815\u201314825 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201191_CR10","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1681\/ASN.2009090944","volume":"21","author":"T Hamano","year":"2010","unstructured":"Hamano, T. et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J. Am. Soc. Nephrol. 21, 1998\u20132007 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ki.2008.700","volume":"75","author":"I Matsui","year":"2009","unstructured":"Matsui, I. et al. Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int. 75, 915\u2013928 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","volume":"361","author":"M Ketteler","year":"2003","unstructured":"Ketteler, M. et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361, 827\u2013833 (2003).","journal-title":"Lancet"},{"key":"BFnrneph201191_CR13","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1111\/j.1523-1755.2005.00345.x","volume":"67","author":"P Stenvinkel","year":"2005","unstructured":"Stenvinkel, P. et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int. 67, 2383\u20132392 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/ndt\/gfh891","volume":"20","author":"AY Wang","year":"2005","unstructured":"Wang, A. Y. et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol. Dial. Transplant. 20, 1676\u20131685 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1523-1755.2005.00172.x","volume":"67","author":"R Mehrotra","year":"2005","unstructured":"Mehrotra, R. et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 67, 1070\u20131077 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/sj.ki.5002549","volume":"72","author":"JH Ix","year":"2007","unstructured":"Ix, J. H. et al. Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int. 72, 1394\u20131399 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00109-007-0294-y","volume":"86","author":"W Jahnen-Dechent","year":"2008","unstructured":"Jahnen-Dechent, W., Sch\u00e4fer, C., Ketteler, M. & McKee, M. D. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J. Mol. Med. 86, 379\u2013389 (2008).","journal-title":"J. Mol. Med."},{"key":"BFnrneph201191_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1172\/JCI109551","volume":"64","author":"JP Lebreton","year":"1979","unstructured":"Lebreton, J. P. et al. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J. Clin. Invest. 64, 1118\u20131129 (1979).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201191_CR19","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/ndt\/gfq053","volume":"25","author":"VM Brandenburg","year":"2010","unstructured":"Brandenburg, V. M. et al. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. Nephrol. Dial. Transplant. 25, 2672\u20132679 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2215\/CJN.02810707","volume":"3","author":"K Caglar","year":"2008","unstructured":"Caglar, K. et al. Short-term treatment with sevelamer increases serum fetuin-A concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin. J. Am. Soc. Nephrol. 3, 61\u201368 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR21","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono, S. et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87, E10\u2013E17 (2000).","journal-title":"Circ. Res."},{"key":"BFnrneph201191_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ki.2008.644","volume":"75","author":"CM Giachelli","year":"2009","unstructured":"Giachelli, C. M. The emerging role of phosphate in vascular calcification. Kidney Int. 75, 890\u2013897 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR23","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1681\/ASN.2004100895","volume":"16","author":"JL Reynolds","year":"2005","unstructured":"Reynolds, J. L. et al. Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J. Am. Soc. Nephrol. 16, 2920\u20132930 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"SM Moe","year":"2002","unstructured":"Moe, S. M. et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 61, 638\u2013647 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","volume":"63","author":"SM Moe","year":"2003","unstructured":"Moe, S. M., Duan, D., Doehle, B. P., O'Neill, K. D. & Chen, N. X. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int. 63, 1003\u20131011 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/ASN.2009060640","volume":"21","author":"RC Shroff","year":"2010","unstructured":"Shroff, R. C. et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J. Am. Soc. Nephrol. 21, 103\u2013112 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1258\/002367798780599758","volume":"32","author":"FA van den Broek","year":"1998","unstructured":"van den Broek, F. A. & Beynen, A. C. The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA\/2 and NMRI mice. Lab. Anim. 32, 483\u2013491 (1998).","journal-title":"Lab. Anim."},{"key":"BFnrneph201191_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI17202","volume":"112","author":"C Schafer","year":"2003","unstructured":"Schafer, C. et al. The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112, 357\u2013366 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201191_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ki.1987.222","volume":"32","author":"HE Meema","year":"1987","unstructured":"Meema, H. E., Oreopoulos, D. G. & Rapoport, A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int. 32, 388\u2013394 (1987).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR30","first-page":"102","volume":"17","author":"I Tzanakis","year":"2004","unstructured":"Tzanakis, I. et al. Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes. Res. 17, 102\u2013108 (2004).","journal-title":"Magnes. Res."},{"key":"BFnrneph201191_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5414\/CNP68222","volume":"68","author":"E Ishimura","year":"2007","unstructured":"Ishimura, E. et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin. Nephrol. 68, 222\u2013227 (2007).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph201191_CR32","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1093\/ndt\/gfq292","volume":"25","author":"AL de Francisco","year":"2010","unstructured":"de Francisco, A. L. et al. Evaluation of calcium acetate\/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol. Dial. Transplant. 25, 3707\u20133717 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ki.2009.126","volume":"76","author":"T Krueger","year":"2009","unstructured":"Krueger, T., Westenfeld, R., Ketteler, M., Schurgers, L. J. & Floege, J. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int. 76, 18\u201322 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"G Luo","year":"1997","unstructured":"Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78\u201381 (1997).","journal-title":"Nature"},{"key":"BFnrneph201191_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.200402046","volume":"165","author":"M Murshed","year":"2004","unstructured":"Murshed, M., Schinke, T., McKee, M. D. & Karsenty, G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J. Cell Biol. 165, 625\u2013630 (2004).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201191_CR36","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1182\/blood-2006-08-040709","volume":"109","author":"LJ Schurgers","year":"2007","unstructured":"Schurgers, L. J. et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109, 2823\u20132831 (2007).","journal-title":"Blood"},{"key":"BFnrneph201191_CR37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.amjcard.2005.05.014","volume":"96","author":"R Koos","year":"2005","unstructured":"Koos, R. et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am. J. Cardiol. 96, 747\u2013749 (2005).","journal-title":"Am. J. Cardiol."},{"key":"BFnrneph201191_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","volume":"15","author":"WA Wilmer","year":"2002","unstructured":"Wilmer, W. A. & Magro, C. M. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin. Dial. 15, 172\u2013186 (2002).","journal-title":"Semin. Dial."},{"key":"BFnrneph201191_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1681\/ASN.2010040339","volume":"22","author":"G Schlieper","year":"2011","unstructured":"Schlieper, G. et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J. Am. Soc. Nephrol. 22, 387\u2013395 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","volume":"152","author":"BD Parker","year":"2010","unstructured":"Parker, B. D. et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann. Intern. Med. 152, 640\u2013648 (2010).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph201191_CR41","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2215\/CJN.07081009","volume":"5","author":"LJ Schurgers","year":"2010","unstructured":"Schurgers, L. J. et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin. J. Am. Soc. Nephrol. 5, 568\u2013575 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1160\/TH07-04-0266","volume":"98","author":"EC Cranenburg","year":"2007","unstructured":"Cranenburg, E. C., Schurgers, L. J. & Vermeer, C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb. Haemost. 98, 120\u2013125 (2007).","journal-title":"Thromb. Haemost."},{"key":"BFnrneph201191_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature09464","volume":"468","author":"K Nakagawa","year":"2010","unstructured":"Nakagawa, K. et al. Identification of UBIAD1 as a novel menaquinone-4 biosynthetic enzyme. Nature 468, 117\u2013121 (2010).","journal-title":"Nature"},{"key":"BFnrneph201191_CR44","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1681\/ASN.2009030319","volume":"20","author":"KE Chan","year":"2009","unstructured":"Chan, K. E., Lazarus, J. M., Thadhani, R. & Hakim, R. M. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J. Am. Soc. Nephrol. 20, 2223\u20132233 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00223-002-1006-9","volume":"71","author":"PA Price","year":"2002","unstructured":"Price, P. A., Omid, N., Than, T. N. & Williamson, M. K. The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption. Calcif. Tissue Int. 71, 356\u2013363 (2002).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrneph201191_CR46","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/01.hjh.0000166849.72721.1c","volume":"23","author":"D Haffner","year":"2005","unstructured":"Haffner, D. et al. Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J. Hypertens. 23, 1067\u20131075 (2005).","journal-title":"J. Hypertens."},{"key":"BFnrneph201191_CR47","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis. 42 (Suppl. 3), S1\u2013S201 (2003).","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"BFnrneph201191_CR48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","volume":"72","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi, M., Finch, J. L., Martin, D. R. & Slatopolsky, E. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int. 72, 709\u2013715 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR49","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2007080902","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew, S., Lund, R. J., Chaudhary, L. R., Geurs, T. & Hruska, K. A. Vitamin D receptor activators can protect against vascular calcification. J. Am. Soc. Nephrol. 19, 1509\u20131519 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR50","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","volume":"165","author":"MD Francis","year":"1969","unstructured":"Francis, M. D., Russell, R. G. & Fleisch, H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165, 1264\u20131266 (1969).","journal-title":"Science"},{"key":"BFnrneph201191_CR51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/01.ATV.0000158943.79580.9d","volume":"25","author":"DA Towler","year":"2005","unstructured":"Towler, D. A. Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. Arterioscler. Thromb. Vasc. Biol. 25, 651\u2013654 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph201191_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/956","volume":"19","author":"A Okawa","year":"1998","unstructured":"Okawa, A. et al. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat. Genet. 19, 271\u2013273 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrneph201191_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.289.5477.265","volume":"289","author":"AM Ho","year":"2000","unstructured":"Ho, A. M., Johnson, M. D. & Kingsley, D. M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289, 265\u2013270 (2000).","journal-title":"Science"},{"key":"BFnrneph201191_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ng1221","volume":"34","author":"F Rutsch","year":"2003","unstructured":"Rutsch, F. et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat. Genet. 34, 379\u2013381 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneph201191_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ndt\/gfp362","volume":"25","author":"WC O'Neill","year":"2010","unstructured":"O'Neill, W. C., Sigrist, M. K. & McIntyre, C. W. Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol. Dial. Transplant. 25, 187\u2013191 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ki.2010.461","volume":"79","author":"WC O'Neill","year":"2011","unstructured":"O'Neill, W. C., Lomashvili, K. A., Malluche, H. H., Faugere, M. C. & Riser, B. L. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int. 79, 512\u2013517 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR57","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s00431-006-0146-8","volume":"165","author":"IM van der Sluis","year":"2006","unstructured":"van der Sluis, I. M., Boot, A. M., Vernooij, M., Meradji, M. & Kroon, A. A. Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up. Eur. J. Pediatr. 165, 590\u2013593 (2006).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrneph201191_CR58","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0272-6386(04)00937-0","volume":"44","author":"K Nitta","year":"2004","unstructured":"Nitta, K. et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am. J. Kidney Dis. 44, 680\u2013688 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201191_CR59","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/ndt\/gfh305","volume":"19","author":"P Monney","year":"2004","unstructured":"Monney, P., Nguyen, Q. V., Perroud, H. & Descombes, E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol. Dial. Transplant. 19, 2130\u20132132 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa0912923","volume":"364","author":"C St Hilaire","year":"2011","unstructured":"St Hilaire, C. et al. NT5E mutations and arterial calcifications. N. Engl. J. Med. 364, 432\u2013442 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201191_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrneph.2009.99","volume":"5","author":"G Schlieper","year":"2009","unstructured":"Schlieper, G., Brandenburg, V., Ketteler, M. & Floege, J. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat. Rev. Nephrol. 5, 539\u2013543 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201191_CR62","unstructured":"Meade, D. et al. Sodium thiosulfate therapy for calciphylaxis in hemodialysis patients [abstract]. American Society of Nephrology Renal Week TH-PO459 (2010)."},{"key":"BFnrneph201191_CR63","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/ki.2008.455","volume":"74","author":"A Pasch","year":"2008","unstructured":"Pasch, A. et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 74, 1444\u20131453 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR64","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/ndt\/gfp755","volume":"25","author":"S Adirekkiat","year":"2010","unstructured":"Adirekkiat, S. et al. Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol. Dial. Transplant. 25, 1923\u20131929 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000323550","volume":"33","author":"SJ Mathews","year":"2011","unstructured":"Mathews, S. J. et al. Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy. Am. J. Nephrol. 33, 131\u2013138 (2011).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201191_CR66","unstructured":"O'Neill, W. C., Hardcastle, K. & Dubyak, G. R. Thiosulfate inhibits vascular calcification in vitro independent of interactions with calcium or hydroxyapatite [abstract]. American Society of Nephrology Renal Week TH-PO131 (2010)."},{"key":"BFnrneph201191_CR67","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block, G. A. et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N. Engl. J. Med. 350, 1516\u20131525 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201191_CR68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejphar.2009.05.013","volume":"616","author":"C Henley","year":"2009","unstructured":"Henley, C. et al. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur. J. Pharmacol. 616, 306\u2013313 (2009).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrneph201191_CR69","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1681\/ASN.2005040342","volume":"17","author":"I Lopez","year":"2006","unstructured":"Lopez, I. et al. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J. Am. Soc. Nephrol. 17, 795\u2013804 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.ki.5002675","volume":"73","author":"I Lopez","year":"2008","unstructured":"Lopez, I. et al. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int. 73, 300\u2013307 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201191_CR71","doi-asserted-by":"publisher","first-page":"F1376","DOI":"10.1152\/ajprenal.90737.2008","volume":"296","author":"I Lopez","year":"2009","unstructured":"Lopez, I. et al. The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats. Am. J. Physiol. Renal Physiol. 296, F1376\u2013F1385 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201191_CR72","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2010","unstructured":"Raggi, P. et al. for the ADVANCE Study Group. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol. Dial. Transplant. 26, 1327\u20131339 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201191_CR73","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2215\/CJN.04381206","volume":"2","author":"GM Chertow","year":"2007","unstructured":"Chertow, G. M. et al. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin. J. Am. Soc. Nephrol. 2, 898\u2013905 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR74","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"RC Shroff","year":"2008","unstructured":"Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118, 1748\u20131757 (2008).","journal-title":"Circulation"},{"key":"BFnrneph201191_CR75","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/ATVBAHA.110.217745","volume":"31","author":"MA Hofmann Bowman","year":"2011","unstructured":"Hofmann Bowman, M. A. et al. S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler. Thromb. Vasc. Biol. 31, 337\u2013344 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph201191_CR76","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2215\/CJN.08310910","volume":"6","author":"Y Shiotsu","year":"2011","unstructured":"Shiotsu, Y. et al. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 6, 718\u2013723 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR77","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1681\/ASN.2009121293","volume":"21","author":"M Wolf","year":"2010","unstructured":"Wolf, M. Forging forward with 10 burning questions on FGF23 in kidney disease. J. Am. Soc. Nephrol. 21, 1427\u20131435 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR78","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","volume":"204","author":"A Van Campenhout","year":"2009","unstructured":"Van Campenhout, A. & Golledge, J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204, 321\u2013329 (2009).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201191_CR79","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1681\/ASN.2007070760","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew, S. et al. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J. Am. Soc. Nephrol. 19, 1092\u20131105 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201191_CR80","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.109.134205","volume":"55","author":"JS Shao","year":"2010","unstructured":"Shao, J. S., Cheng, S. L., Sadhu, J. & Towler, D. A. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55, 579\u2013592 (2010).","journal-title":"Hypertension"},{"key":"BFnrneph201191_CR81","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","volume":"178","author":"A Pai","year":"2011","unstructured":"Pai, A., Leaf, E. M., El-Abbadi, M. & Giachelli, C. M. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am. J. Pathol. 178, 764\u2013773 (2011).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201191_CR82","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z. & Curhan, G. for the Cholesterol And Recurrent Events Trial Investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627\u20132633 (2005).","journal-title":"Circulation"},{"key":"BFnrneph201191_CR83","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra, R. et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch. Intern. Med. 167, 879\u2013885 (2007).","journal-title":"Arch. Intern. Med."},{"key":"BFnrneph201191_CR84","doi-asserted-by":"publisher","first-page":"c3691","DOI":"10.1136\/bmj.c3691","volume":"341","author":"MJ Bolland","year":"2010","unstructured":"Bolland, M. J. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691 (2010).","journal-title":"BMJ"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.91.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.91","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.91.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:37:15Z","timestamp":1741325835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2011.91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,19]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFnrneph201191"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2011.91","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,19]]}}}